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Abstract. 
 
Occludin is the only known integral mem-
brane protein localized at the points of membrane–
membrane interaction of the tight junction. We have 
 
used the 
 
Xenopus
 
 embryo as an assay system to exam-
ine: (
 
a
 
) whether the expression of mutant occludin in 
embryos will disrupt the barrier function of tight junc-
tions, and (
 
b
 
) whether there are signals within the oc-
cludin structure that are required for targeting to the 
sites of junctional interaction. mRNAs transcribed 
from a series of COOH-terminally truncated occludin 
mutants were microinjected into the antero–dorsal 
blastomere of eight-cell embryos. 8 h after injection, 
the full-length and the five COOH-terminally trun-
cated proteins were all detected at tight junctions as de-
fined by colocalization with both endogenous occludin 
and zonula occludens-1 demonstrating that exogenous 
occludin correctly targeted to the tight junction. Impor-
tantly, our data show that tight junctions containing 
four of the COOH-terminally truncated occludin pro-
teins were leaky; the intercellular spaces between the 
apical cells were penetrated by sulfosuccinimidyl-6-(bi-
otinamido) Hexanoate (NHS-LC-biotin). In contrast, 
embryos injected with mRNAs coding for the full-
length, the least truncated, or the soluble COOH termi-
nus remained impermeable to the NHS-LC-biotin 
tracer. The leakage induced by the mutant occludins 
could be rescued by coinjection with full-length occlu-
din mRNA. Immunoprecipitation analysis of deter-
gent-solubilized embryo membranes revealed that the 
exogenous occludin was bound to endogenous 
 
Xenopus
 
 
occludin in vivo, indicating that occludin oligomerized 
during tight junction assembly. Our data demonstrate 
that the COOH terminus of occludin is required for the 
correct assembly of tight junction barrier function. We 
also provide evidence for the first time that occludin 
forms oligomers during the normal process of tight 
junction assembly. Our data suggest that mutant occlu-
dins target to the tight junction by virtue of their ability 
to oligomerize with full-length endogenous molecules.
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Boston, MA 02115. Tel.: (617) 432-1652. Fax: (617) 432-2955. e-mail:
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T
 
ight
 
 junctions, the most apical component of the
junctional complex (Farquhar and Palade, 1963),
form selective permeability barriers along the para-
cellular pathways of epithelial and endothelial cells (Dia-
mond, 1977; Gumbiner, 1990; Reuss, 1989). Tight junc-
tions also act as a “fence” between the apical and lateral
plasma membrane domains to prevent the mixing of mem-
brane lipids and proteins between these two compart-
ments (van Meer et al., 1986; Cereijido et al., 1989;
Schneeberger and Lynch, 1992). In response to different
stimuli, tight junctions rapidly change their permeability
and functional properties, permitting dynamic fluxes of
ions and solutes as well as transepithelial passage of whole
cells (Claude and Goodenough, 1973; Duffey et al., 1981;
Kachar and Pinto da Silva, 1981; Mazariegos et al., 1984;
Milks et al., 1986; Madara and Pappenheimer, 1987; Pap-
penheimer, 1987, 1990; Pappenheimer and Reiss, 1987).
At least seven proteins (zonula occludens-1 and -2 [ZO-1,
ZO-2], cingulin, 7H6, rab 13, occludin, and symplekin) are
found to be localized at tight junctions (Citi et al., 1988;
Gumbiner et al., 1991; Furuse et al., 1993; Zhong et al.,
1993; Jesaitis and Goodenough, 1994; Zahraoui et al.,
1994; Ando-Akatsuka et al., 1996; Keon et al., 1996).
Among these proteins, occludin is the only integral mem-
brane protein localized at the points of membrane–mem-
brane interaction of tight junctions as revealed by immu-
nogold labeling of thin-sections and freeze-fracture replicas
(Furuse et al., 1993; Fujimoto, 1995). Hydropathy analysis
predicts that occludin has four transmembrane domains,
two extracellular loops, and a long COOH-terminal cyto-
plasmic tail consisting of 255 amino acids (Furuse et al.,
1993; Ando-Akatsuka et al., 1996). By transfection of vari-
ous deletion mutants of chicken occludin into Madin-
Darby bovine kidney (MDBK) cells, Furuse et al. (1994)
showed that the COOH-terminal 
 
z
 
150 amino acids (do-
main E358/504) were necessary for the localization of oc-
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cludin at tight junction. Their in vitro binding assay also in-
dicated that domain E358/504 directly associated with
ZO-1. However, recent data reported by Balda et al. (1996)
showed that COOH-terminally truncated chicken occludin
localized efficiently to the tight junction in transfected
MDCK cells. The discrepancy between these experiments
raises the question of whether COOH terminus of occlu-
din is required for targeting.
Three experiments with cell culture systems indicate that
occludin is directly involved in the sealing function of the
tight junction. First, in the experiments outlined above
(Balda et al., 1996), expression of a COOH-terminally
truncated occludin resulted in an electrically tighter para-
cellular pathway that paradoxically had an increased para-
cellular flux of solutes. Second, McCarthy et al. (1996)
transfected MDCK cells with chicken occludin cDNA in a
Lac-inducible expression vector. Isopropyl-
 
b
 
-
 
d
 
-thiogalac-
toside (IPTG)
 
1
 
–induced expression of chicken occludin in-
creased transepithelial resistance (TER) by 30–40%, which
declined back to uninduced states after removal of IPTG
from the culture medium. Freeze fracture showed an in-
crease in the mean number and complexity of branching of
tight junctional strands, together with a concomitant in-
crease in the apical–basal width of the tight junction
network. McCarthy et al. (1996) also observed the para-
doxical transepithelial mannitol flux which progressively
increases as TER increases. Third, Wong and Gumbiner
(1997) found that a synthetic peptide (OCC2), correspond-
ing to the second extracellular domain of occludin, revers-
ibly disrupted the transepithelial permeability barrier
when added to 
 
Xenopus
 
 kidney epithelial A6 cell mono-
layers. In these experiments, OCC2 decreased TER and
increased the paracellular flux of tracers.
We have investigated the ability of mutant occludin
molecules to assemble in tight junctions during the biogen-
esis of an epithelium in an intact organism. mRNAs coding
for a series of COOH-terminally truncated chicken occlu-
din molecules have been expressed in the 
 
Xenopus
 
 em-
bryo. All exogenous proteins were FLAG tagged at the
COOH terminus to permit discrimination from endoge-
nous molecules and were seen to target to the tight junc-
tion by immunofluorescence. Four of the COOH-termi-
nally truncated mutants caused the disruption of the tight
junction solute seal as assayed by a novel surface biotinyla-
tion method. Exogenous and endogenous occludins could
be coimmunoprecipitated under nondenaturing conditions
as oligomeric complexes. These data indicate that the
truncated, mutant occludins are targeted to the tight junc-
tion in association with intact, endogenous molecules.
 
Materials and Methods
 
Construction of Full-Length and Truncated Occludins
 
A full-length chicken occludin cDNA (a generous gift from S. Tsukita,
Kyoto University, Japan) was subcloned into the expression vector SP64T
by PCR. The sequence of PCR sense primer was as follows: 5
 
9
 
-TGG GCC
ACC ATG TTC AGC AAG AAG-3
 
9
 
, which corresponded to the NH
 
2
 
-
terminal 15 codons of chicken occludin plus 9 bp preceding the start
codon. The antisense primer corresponded to the last 15 codons of the
COOH terminus of occludin plus the BglII site and three restriction sites,
which formed a linker between the occludin and the FLAG epitope: 5
 
9
 
-
GCC TAC GAC AAG GTG CGG GAG ATC TTC GCG ATA TCA
AGG CCT GAC TAC AAG GAC GAC GAT GAC AAG TAA-3
 
9
 
.
These restriction sites permitted placing the FLAG-coding sequence in
frame with each truncation. Using these primers, a 1.6-kb occludin cDNA
with the FLAG epitope tag was amplified by Vent polymerase (New En-
gland Biolabs Inc., Beverly, MA) with full-length occludin cDNA in
pBluescript SK(
 
2
 
) as a template. The PCR products were phosphory-
lated, separated by agarose gel electrophoresis, and purified by Gel Ex-
traction Kit (QIAGEN Inc., Chatsworth, CA). The purified occludin
DNA was cloned into the BglII site of the expression vector SP64T (Krieg
and Melton, 1984).
A nested set of five occludin constructs truncated in the COOH-termi-
nal domain predicted to face the cytoplasm was prepared by endonuclease
digestion of the full-length occludin construct described above. Each trun-
cated occludin was then blunt ligated after the reading frame alignment by
endonuclease digestion of the restriction sites located upstream of FLAG-
coding region. In addition, a construct was prepared that coded for the ini-
tial 20 amino acids of the NH
 
2
 
 terminus fused to the complete COOH ter-
minus beginning at amino acid 266 and including the FLAG epitope tag.
The full-length construct was sequenced using AmpliCycle Sequencing
Kit (Perkin Elmer Corp., Norwalk, CT) to ensure that the occludin se-
quence and the FLAG epitope tag were intact and in the correct reading
frame.
 
Production of Anti-occludin and Anti-ZO-1 Sera
 
The fusion protein containing glutathione-S-transferase (GST) and the
COOH terminus of chicken occludin (250 amino acids) was constructed
using pGEX-3 vector (Smith and Johnson, 1988). An overnight bacterial
culture was diluted in Luria-Bertani medium with 0.01% ampicillin, and
grown for 2–3 h at 37
 
8
 
C. The synthesis of the fusion protein was induced
by adding 0.2 mM IPTG. After 4–5 h of induction, cells were collected by
centrifugation at 2,100 
 
g
 
 for 10 min, and resuspended in PBS. The cell sus-
pension was sonicated 1 min on ice with 1% Triton X-100, and centrifuged
at 5,100 
 
g
 
 for 15 min. The supernatant was incubated with glutathione–
agarose beads (Sigma Chemical Co., St. Louis, MO) for 30 min at 4
 
8
 
C,
washed three times with PBS, and then the bound fusion proteins were re-
leased by adding 5 mM glutathione. The full-length fusion protein was
separated on 12% SDS-polyacrylamide gel and purified by electroelution.
Two rabbits were injected with purified fusion protein to raise poly-
clonal antibodies (Pocono Rabbit Farm and Laboratory, Canadensis,
PA). The resulting 11350 and 11351 antisera were affinity purified on a
Sepharose 4B column containing 1 mg purified fusion protein. This anti–
chicken occludin antibody cross-reacted with 
 
Xenopus
 
 occludin both in
immunoblots and in immunohistochemistry.
The anti–ZO-1 antiserum was prepared by immunizing with a GST–
ZO-1 fusion protein. A construct was made consisting of the pGEX-1 ex-
pression vector containing 1.8 kb of human ZO-1 sequence spanning the
alternative splice site (the generous gift of J. Anderson, Yale University,
New Haven, CT). The process of preparation and affinity purification of
the antiserum against GST–ZO-1 was the same as described above for the
GST–occludin construct.
 
In Vitro Transcription and Microinjection of mRNA 
into Xenopus Oocytes and Embryos
 
The SP64T vectors containing either wild type or mutant chicken occlu-
dins were linearized with BamHI and transcribed in vitro with SP6 RNA
polymerase (Ambion Inc., Austin, TX). Adult female 
 
Xenopus laevis
 
were obtained from a departmental frog facility (Department of Cell Biol-
ogy, Harvard Medical School, Boston, MA). Oocytes were collected and
defolliculated according to published protocols (Swenson et al., 1989).
Oocytes were microinjected in their vegetal hemispheres with 40 nl (
 
z
 
100
pg) RNA or water, and incubated at 17
 
8
 
C overnight for immunoblot or
immunoprecipitation experiments.
Fertilized embryos were obtained as described previously (Paul et al.,
1995). The anterior, dorsal blastomere of eight-cell embryos were injected
with 4 nl (
 
z
 
10 pg) of FLAG-tagged, full-length or truncated chicken oc-
cludin RNA. 6–8 h after injection, embryos were either directly embedded
in TISSUE-TEK embedding medium (Miles Inc., Elkhart, IN) without
 
1.
 
 Abbreviations used in this paper
 
: CT, COOH terminus; GST, glu-
tathione-S-transferase; IPTG, isopropyl-
 
b
 
-
 
d
 
-thiogalactoside; NHS-LC-bi-
otin, sulfosuccinimidyl isopropyl-6-(biotinamido) Hexanoate; TER, trans-
epithelial resistance; ZO, zonula occludens. 
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fixation and quickly frozen in liquid propane or used for surface biotinyla-
tion experiments (see below).
 
Cell Culture and Metabolic Labeling
 
The A6 
 
Xenopus
 
 kidney epithelial cells (kindly provided by B. Gumbiner,
Sloan-Kettering Institute, New York) were grown in 61% Leibovitz L15
medium (GIBCO BRL, Gaithersburg, MD) supplemented with 5% FCS
(Hyclone Laboratories, Logan, UT), 100 U/ml penicillin and 0.1 mg/ml
streptomycin, and 45 mM NaHCO
 
3
 
, pH 7.3, at 27
 
8
 
C in a humidified incu-
bator with 5% CO
 
2
 
. Cells were metabolically labeled for 20 h at 27
 
8
 
C with
150 
 
m
 
Ci/ml Tran
 
35
 
S-label ([
 
35
 
S]met/[
 
35
 
S]cys; ICN Radiochemicals, Cleve-
land, OH) in 70% methionine-free medium (GIBCO BRL) supplemented
with 5% dialyzed FCS (Sigma Chemical Co.). At the end of the labeling
period cells were rinsed three times in ice-cold 0.65
 
3
 
 PBS and extracted
with the same immunoprecipitation buffer used for 
 
Xenopus
 
 embryos
(vide infra).
 
Immunoprecipitation
 
RNA-injected 
 
Xenopus
 
 oocytes or embryos were rinsed three times with
PBS and homogenized on ice by passing 20 times through a 22-gauge nee-
dle in lysis buffer (5 mM EDTA, 5 mM EGTA, 5 mM Tris, pH 8.0) with 10
 
m
 
g/ml each of chymostatin, leupeptin, and pepstatin A, 0.01% diisopropyl-
fluorophosphate, and 20 
 
m
 
M PMSF. The homogenates were centrifuged
at 3,000 
 
g
 
 for 10 min at 4
 
8
 
C to pellet yolk granules. The supernatants were
then centrifuged at 100,000 
 
g
 
 at 4
 
8
 
C for 30 min. The membrane pellet was
resuspended in lysis buffer plus SDS-PAGE sample buffer to a final con-
centration of two oocytes per 10 
 
m
 
l for immunoblot. For immunoprecipi-
tation experiments, the membrane pellet was resuspended in IP buffer
(1% Triton X-100, 0.5% deoxycholic acid, 0.2% SDS, 150 mM NaCl, 10
mM Hepes, 2 mM EDTA, 10 KIU/ml Trasylol, 10 
 
m
 
g/ml each of chymo-
statin, leupeptin, and pepstatin A, and 0.01% diisopropylfluorophos-
phate), incubated on ice for 30 min, and then centrifuged at 100,000 
 
g
 
 for
1 h at 4
 
8
 
C. The supernatants were either incubated with primary antibody
directly or mixed with 
 
35
 
S-labeled A6 cell lysates first, and then incubated
with primary antibody overnight at 4
 
8
 
C. The samples were incubated with
either protein A–Sepharose CL-4B or protein G–Sepharose 4B (Sigma
Chemical Co.) for an additional 2 h at 4
 
8
 
C. After three washes in IP
buffer, one in high salt (0.5 M NaCl, 10 mM Tris), and one in 10 mM Tris
buffer, the samples were solubilized in SDS-PAGE sample buffer.
 
SDS Gel Electrophoresis and Immunoblotting
 
Samples were boiled in SDS-PAGE sample buffer for 3 min and sepa-
rated on 10 or 12% SDS-polyacrylamide minigels. The proteins were then
transferred onto an Immobilon membrane (Millipore Corp., Bedford,
MA). The membrane was blocked 1 h at room temperature with 5% low-
fat milk in TBS plus 0.1% Tween 20, and then incubated at room temper-
ature for 2 h with anti-occludin antibody diluted at 1:1,000 or anti-FLAG
monoclonal antibody used at 10 
 
m
 
g/ml. The primary antibodies were de-
tected by alkaline phosphatase–conjugated goat anti–rabbit IgG (Promega
Corp., Madison, WI), or goat anti–mouse IgG (Boehringer Mannheim
Biochemicals, Indianapolis, IN) used at 1:5,000 or 1:1,000. To reduce the
background the secondary antibodies were preabsorbed with a crude 
 
Xe-
nopus
 
 oocyte homogenate before reaction with the Immobilon mem-
branes. After 1-h incubation with secondary antibody at room tempera-
ture, the blots were washed three times with TBS before the color
reaction was developed according to the manufacturer’s instructions.
 
Surface Biotinylation–Tight Junction
Permeability Assay
 
6 h after RNA injection, 
 
Xenopus
 
 embryos were cooled to 10
 
8
 
C for 5 min
before transferring to freshly made 1 mg/ml NHS-LC-Biotin (Pierce
Chemical Co., Rockford, IL) in 0.1 
 
3
 
 MMR solution (0.1 M NaCl, 2 mM
KCl, 1 mM MgSO
 
4
 
, 2 mM CaCl
 
2
 
·2H
 
2
 
O, 0.1 mM EDTA, and 5 mM Hepes,
pH 7.8). After 12 min of labeling with biotin at 10
 
8
 
C, the embryos were
washed twice with 0.1 
 
3
 
 MMR, and fixed at 4
 
8
 
C overnight in 3% formal-
dehyde made fresh from paraformaldehyde in 80 mM sodium cacodylate,
pH 7.4. Embryos were rinsed with PBS and embedded in TISSUE-TEK
and cryosectioned. 14-
 
m
 
m frozen sections were incubated in blocking
buffer (1% fish skin gelatin and 1% BSA in PBS) for at least 5 h. Anti–
FLAG M2 antibody diluted 1:200 in blocking buffer was then placed on
the sections and incubated at 4
 
8
 
C overnight. After washing three times
with blocking buffer, sections were then incubated with preadsorbed
FITC-conjugated goat anti–mouse IgG (Boehringer Mannheim Biochem-
icals) and RITC-avidin (Pierce Chemical Co.), both diluted 1:500 in block-
ing buffer. Anti–FLAG M2 antibody was used to identify the region of
RNA injection. Control embryos were warmed to 18
 
8
 
C after biotinylation
and allowed to develop to tadpole stages. The 12-min labeling time was
chosen since this was the maximum time at 10
 
8
 
C, which was 100% conso-
nant with normal development of embryos to tadpole stages.
 
Immunofluorescence
 
Frozen embryos were sectioned on a cryostat HM 500 OM (MICROM;
Carl Zeiss, Inc., Thornwood, NY) at 10 
 
m
 
m. The tissues were fixed in
100% methanol for 3 min at 
 
2
 
20
 
8
 
C, and blocked with 1% fish skin gelatin
plus 1% BSA in PBS for at least 5 h. The sections were double-stained
with the affinity-purified anti-occludin antibody 11350 at 1:500 dilution
and anti-FLAG monoclonal antibody M2 diluted at 1:200 (Eastman Kodak
Co., Rochester, NY) 1 h at room temperature or 4
 
8
 
C overnight. Sections
were washed three times, 10 min each in blocking medium, and then incu-
bated for 1 h at room temperature with FITC-conjugated goat anti–rabbit
IgG (Boehringer Mannheim Biochemicals) diluted 1:500 and rhodamine-
conjugated goat anti–mouse IgG (Cappel Laboratories, Malvern, PA) di-
luted 1:500, which both were preabsorbed with a crude 
 
Xenopus
 
 oocyte
homogenate. Sections were examined by epifluorescence using a Zeiss
Axioskop (Carl Zeiss, Inc.) and photographed with TMAX-400 film
(Eastman Kodak Co.).
 
Results
 
Full-Length and Truncated Chicken Occludins Can Be 
Expressed in Xenopus Oocytes
 
Full-length chicken occludin, a nested set of five COOH-
terminally truncated occludins, and a soluble construct
consisting of 20 NH
 
2
 
-terminal amino acids fused to the oc-
cludin COOH terminus were subcloned into the SP64T
vector. These constructs are diagrammed in Fig. 1 (
 
504,
486, 385, 336 320, 266
 
, and 
 
CT
 
). The nomenclature indi-
cates the deletion site in each protein and CT represents
COOH terminus. The constructs have FLAG epitope tags
attached to the COOH terminus of the molecule to distin-
guish exogenous chicken occludin from endogenous 
 
Xeno-
pus
 
 occludin, since our polyclonal anti–chicken occludin
cross-reacted with 
 
Xenopus
 
 occludin. The mRNAs tran-
scribed from these seven constructs were microinjected
into 
 
Xenopus
 
 oocytes and the results analyzed by immu-
noblots shown in Fig. 2. The data in Fig. 2 
 
a
 
 were obtained
by immunoblotting with anti-occludin antibody 11350, and
in Fig. 2 
 
b
 
 with anti-FLAG antibody M2. Fig. 2 demon-
strates that all proteins were equivalently expressed in 
 
Xe-
nopus
 
 oocytes. The asterisks at the right side of each lane
in both 
 
a
 
 and 
 
b
 
 indicate the predicted molecular weight of
each protein. In addition, all occludin molecules that con-
tained the four membrane-spanning domains formed pre-
sumed dimers in SDS gel sample buffer under reducing
conditions as marked by arrowheads in both 
 
a
 
 and 
 
b.
 
 The
aggregation of occludin in SDS is not an indication of the
state of association between occludin proteins in vivo. This
SDS-induced aggregation is a phenomenon shared with
some of the members of the gap junction connexin family
of proteins, particularly connexin 32 (Hertzberg and Gi-
lula, 1979; Goodenough et al., 1988). Proteins 385 and 320
migrated as doublets whose identity was not investigated.
It is possible that doublets were caused by posttransla-
tional modifications in certain deletion constructs or were
caused by degradation. All preparations were prepared 
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from oocyte membrane fractions except CT, which was
obtained from soluble supernatant fractions. A small
amount of CT protein could be detected in membrane
fractions, although full-length protein could not be de-
tected in supernatants (data not shown). Fig. 2 also shows
that all expressed proteins were recognized by both the
11350 antiserum and the anti–FLAG M2 monoclonal anti-
body, except 266, which lacked almost the entire COOH
terminus and was not recognized by 11350.
 
Disruption of Tight Junction Permeability Barrier by 
Four COOH-terminally Truncated Occludins
 
We used a novel surface biotinylation method to examine
the permeability of tight junctions in the embryo. During
the normal development of 
 
Xenopus
 
 embryos, biotin mol-
ecules are blocked from entry to restricted intercellular
spaces beginning at the two-cell stage, suggesting that the
formation of functional tight junctions and formation of
the blastocoele begin at the first cleavage (Slack and
Warner, 1973; Merzdorf, C., Y.-H. Chen, and D.A. Good-
enough, manuscript in preparation). When mRNAs from
constructs 504 (full-length), 486 (the least COOH-termi-
nally truncated), and CT (COOH terminus only) were in-
jected into eight-cell stage embryos, the results were iden-
tical to embryos injected with only water: tight junctions
were impermeable to the biotin tracer (Fig. 3, 
 
a
 
 and 
 
b
 
; data
not shown for CT). NHS-LC-biotin labeled the vitelline
envelope and apical blastomere membranes, which appear
together as a single thick line at the surface of the embryo
(Fig. 3, 
 
a
 
 and 
 
b
 
). No signal was detectable between the
blastomeres in the intercellular spaces. However, if the
embryos were injected with mRNAs from the four
COOH-terminally truncated constructs 385, 336, 320, and
266, the intercellular spaces between epithelial cells were
penetrated by biotin (Fig. 3, 
 
c
 
–
 
f
 
), indicating that there is a
critical region between residues 486 and 385 that is re-
quired for correct assembly critical for the tight junctional
seal. Fig. 3 
 
c
 
 (
 
arrowhead
 
) reveals that the membranes of
internal cells beneath those at the embryonic surface have
also been biotinylated, indicating that the tracer pene-
trated beyond the first tier of cells. This observation indi-
cates that the truncated occludin molecules must have al-
tered the permeability function of the tight junctions.
Double labeling of sections with both the avidin and anti–
FLAG M2 antibody revealed that the leaks occurred only
between blastomeres expressing the truncated occludin
proteins; the tight junctions between the blastomeres unla-
beled by M2 within the same embryo were well sealed
(data not shown).
These dominant-negative effects of the truncated occlu-
din mutants were sensitive to dilution and to competition
from wild-type protein. Leaks between blastomeres were
observed when truncated occludin mRNAs were diluted 1:
10 but not 1:50 (data not shown). The induced tight-junc-
tional leakage could be rescued by coinjection of an equal
amount of mRNA from construct 504 (full-length) to-
gether with mRNA from construct 266. Fig. 4 shows the
biotin staining of 
 
Xenopus
 
 embryos 6 h after injection of
mRNAs from construct 504 (
 
a
 
), 266 (
 
b
 
), and 266 with 504
together (
 
c
 
). Coinjection of 504 and 266 mRNAs together
resulted in no detectable leak between the blastomeres
(Fig. 4 
 
c
 
).
 
Targeting of Exogenous Chicken Occludin to Tight 
Junctions in Early Xenopus Embryos
 
Full-length occludin, as well as all truncated mutants,
could be localized to tight junctions in early 
 
Xenopus
 
 em-
bryos except for the soluble CT. Fig. 5 shows an example
of exogenous truncated occludin protein colocalized with
endogenous full-length 
 
Xenopus
 
 occludin. Frozen sections
Figure 1. Schematic drawing of full-length (504) and six trun-
cated chick occludin proteins that were subcloned into expression
vector SP64T. Each molecule has a FLAG epitope tag (black
box) at the end of COOH terminus to distinguish it from Xeno-
pus occludin. The shaded half of the molecule is predicted to
traverse the membrane four times, and contains an NH2 terminus
facing the cytoplasm, two extracellular loop domains, and one cy-
toplasmic loop domain. The unshaded half of the protein is pre-
dicted to face the cytoplasm. The numbers on the right indicate
the total number of amino acids in each protein. CT, soluble
NH2-terminal 20 amino acids fused to the predicted cytoplasmic
tail; N, NH2 terminus; C, COOH terminus.
Figure 2. Western blot analysis of Xenopus oocytes injected with
mRNAs corresponding to the occludin proteins diagrammed in
Fig. 1. mRNAs were microinjected in the vegetal hemisphere of
stage VI oocytes, and the injected oocytes were incubated at 178C
overnight. Oocyte homogenates were separated on 12% SDS-
PAGE, transferred to Immobilon membranes, and then immuno-
blotted with either anti-occludin antibody 11350 (a) or with anti-
FLAG monoclonal antibody M2 (b). The number on the top of
each lane identifies each protein as named in Fig. 1. The asterisks
in a and b indicate the predicted position of each expressed pro-
tein. With the exception of the soluble CT, the expressed proteins
formed dimers as indicated by the arrowheads. Note that protein
266, with almost the entire COOH terminus deleted, was not rec-
ognized by 11350 antibody. H2O, control oocytes injected with
water. Molecular weight markers (from top to bottom): 97.4, 66,
45, and 31 kD.Chen et al. Occludin and Tight Junction Function 895
of embryos injected with construct 266 mRNA (the most
COOH-terminally truncated one) were double stained
with anti-occludin polyclonal antibody 11350 (Fig. 5 a) and
anti-FLAG monoclonal antibody M2 (Fig. 5 b). In Fig. 5,
the extraembryonic space is oriented toward the top of the
figure and the blastocoele is oriented toward the bottom.
As the apical regions of the blastomeres remained in the
plane of section for variable distances, the linear tight
junction staining (Fig. 5, a and b, arrowheads) was sampled
such that the staining appeared as single or branching slen-
der threads outlining those portions of the apical cellular
surfaces contained in the section. Since the anti-occludin
11350 did not recognize 266 mutant occludin (Fig. 2 a, lane
266), the signal in Fig. 5 a came from only endogenous full-
length occludin, while the signal in Fig. 5 b localized the
most COOH-terminally truncated exogenous occludin. In
addition, all expressed exogenous proteins contained cyto-
plasmic staining. The colocalization of anti-occludin (Fig.
5 a) and anti-FLAG (Fig. 5 b) demonstrated that a fraction
of the expressed exogenous occludin had been correctly
targeted to tight junctions.
While the anti-FLAG antibody revealed threadlike stain-
ing patterns with all constructs (data not shown), double
labeling with anti-FLAG and anti-occludin to demonstrate
colocalization was ambiguous since the anti-occludin re-
agent recognized both exogenous and endogenous mole-
cules except for construct 266 (shown in Fig. 5). For this
reason, exogenous occludin mutants were colocalized with
another tight junction marker ZO-1. Fig. 6 shows immuno-
fluorescence photographs of frozen sections of an embryo
injected with construct 266 mRNA, double stained with
anti–ZO-1, an independent marker for the position of the
tight junction (Stevenson et al., 1986), and anti-FLAG M2.
The staining revealed a colocalization of the most COOH-
terminally truncated exogenous occludin with endogenous
ZO-1, indicating the targeting of mutant occludin to the
junctional complex, even though it lacked almost the en-
tire COOH terminus, which contains the binding domain
to ZO-1. The full-length and the other four COOH-termi-
nally truncated chicken occludin proteins were all local-
ized at tight junctions in a similar pattern as shown in Figs.
5 and 6 (data not shown). For construct CT, which encodes
Figure 3. Functional assay
of tight junctions by surface
biotinylation in Xenopus em-
bryos injected with chicken
full-length or truncated oc-
cludins. 6 h after mRNA in-
jection (2,000 cell blastula),
the embryos were labeled by
incubation in 1 mg/ml NHS-
LC-biotin for 12 min at 108C,
washed, and then fixed in 3%
formaldehyde in 80 mM so-
dium cacodylate. Frozen sec-
tions were stained with RITC-
avidin and observed by
fluorescence microscopy. In all
embryos, NHS-LC-biotin
reacts with molecules in the
vitelline envelope, the subvi-
telline space, and the apical
plasma membranes of the
blastomeres, which together
appear as a thick, continuous
line at the surface of the em-
bryo. The tight junctions in
the embryos injected with
504 (a, the full-length) or 486
(b, the least COOH-termi-
nally truncated) occludin
mRNAs deny the biotin ac-
cess to the intercellular spaces,
and the basolateral mem-
branes of the blastomeres are
not stained. In the embryos
injected with 385 (c), 336 (d)
320 (e), and 266 (f) (four
COOH-terminally truncated
occludin mRNAs), the biotin
molecules penetrated into in-
tercellular spaces demonstrat-
ing the disruption of the tight
junction seal. Bar, 10 mm.The Journal of Cell Biology, Volume 138, 1997 896
a soluble COOH-terminal peptide, the anti-FLAG signal
was in the cytoplasm and was not detectable at the tight
junction (data not shown). By sampling embryos at differ-
ent developmental stages, FLAG-tagged chicken occlu-
dins were detectable at the tight junctions by 4 h after in-
jection. By 20 h after injection, immunofluorescence signals
for the FLAG epitope were significantly decreased, which
may be due to the degradation or dilution of the injected
mRNA.
Immunoprecipitation Revealed
Interactions between Endogenous Xenopus Occludin 
and Exogenous Chicken Occludin In Vivo
The fact that our polyclonal antiserum was unable to rec-
ognize construct 266, which lacked most of the cytoplasmic
COOH terminus (see Fig. 2), offered an opportunity to in-
vestigate possible interactions between endogenous occlu-
din and the mutant 266 by immunoprecipitation of deter-
gent extracts. Embryos injected with mRNA from the
construct 266 were detergent solubilized and immunopre-
cipitated with anti-occludin 11350 or anti-FLAG M2. Af-
ter SDS-PAGE and electrophoretic transfer, the immuno-
precipitates were then immunoblotted with anti-FLAG
M2 or anti-occludin antibodies to probe for potential in-
teractions between the native and truncated molecules. In
Fig. 7, a and b, left lanes are immunoblots of immunopre-
cipitates from embryos injected with 266 mRNA; right
lanes are samples from embryos without mRNA injection.
Fig. 7 a (left lane) shows a 11350 immunoprecipitate blot-
ted with anti-FLAG M2, and Fig. 7 b (left lane) shows an
anti-FLAG immunoprecipitate blotted with 11350. In each
case, immunoblotting reveals that each immunoprecipitate
contains the alternate antigen, demonstrating that the en-
dogenous and truncated occludins were both contained in
a common detergent-soluble structure. Samples incubated
with rabbit preimmune serum or with only protein A–Seph-
arose beads showed no specific signal. Similar coimmuno-
precipitation results were obtained from oocytes injected
with 266 mRNA (data not shown), indicating that the as-
Figure 4. Coinjection of the full-length (504) occludin mRNA
with the most COOH-terminally truncated occludin mRNA
(266) rescued the tight junction leakage caused by injection of
construct 266 alone. The experimental procedure was same as in
Fig. 3. The frozen sections from the embryos injected with z2 pg
of 504 (a), 266 (b), or 504 and 266 (c) construct mRNA were
stained with RITC-avidin. The extraembryonic space is toward
the top of figure in a, and left in b and c. No leak was seen in the
embryo infected with 504 mRNA (a). Biotin molecules clearly
penetrated through the tight junctions and labeled the intercellu-
lar spaces between the apical cells of embryo injected with 266
mRNA (b). However, there was no detectable leak in the embryo
injected with both 504 and 266 mRNA (c). Bar, 15 mm.
Figure 5. Double labeling of frozen sections of Xenopus embryos
with anti-occludin 11350 (a) and anti-FLAG M2 (b). 4 nl (z10
pg) of mutant 266 mRNA were microinjected into the anterior,
dorsal blastomere of eight-cell stage embryo and incubated for 8 h
at room temperature before freezing. The arrowheads indicate
the colocalization of Xenopus full-length occludin and chicken
truncated occludin at the junctional complexes. Bar, 10 mm.Chen et al. Occludin and Tight Junction Function 897
sociation of the mutant and endogenous occludin could
occur in the absence of tight junction formation.
To demonstrate that the association of Xenopus occlu-
din with chicken truncated occludin did not arise by sub-
unit exchange between the detergent-solubilized forms
of occludin during experimental manipulations, we per-
formed an experiment in which radiolabeled, detergent-
solubilized occludin from A6 cells was mixed and incu-
bated in vitro with solubilized occludin from embryos (Fig.
8). After solubilization in detergent, the high speed super-
natants from embryos injected with construct 266 mRNA
were mixed with similarly solubilized [35S]methionine-
labeled A6 cell lysates to test whether the radiolabeled oc-
cludin could be immunoprecipitated with the anti-FLAG
antibody. The embryo and A6 detergent extracts were
mixed, incubated, and then immunoprecipitated with ei-
ther anti-occludin antibody (Fig. 8, left lane), anti-FLAG
M2 (Fig. 8, center lane), or rabbit preimmune serum (Fig.
8, right lane). The immunoprecipitates were examined by
SDS-PAGE and autoradiography. The 35S-occludin band
was detectable only in the left lane (arrowhead), not in the
middle or right lanes, indicating that radiolabeled occludin
did not exchange between solubilized structures in deter-
gent solutions. The top band in all three lanes was nonspe-
cific. Therefore, the interaction of Xenopus full-length oc-
cludin with chicken truncated occludin was not an artifact of
subunit exchange under detergent-solubilization conditions.
Discussion
We demonstrate in the present study that expression of
occludin mutants in the early Xenopus embryo resulted in
the disruption of the transepithelial permeability barrier
to solutes. Embryos injected with mRNAs encoding full-
length occludin or the soluble occludin COOH terminus
remained impermeable to a biotin tracer. Removal of the
ultimate 18 amino acids of the occludin molecule was not
sufficient to cause the leaky phenotype; only mutants
which were truncated by 119 amino acids or more had the
disruptive activity. The leaky phenotype could be rescued
by coinjection of full-length and truncated occludin
mRNA, indicating that the disruption of the permeability
seal was not a nonspecific effect of exogenous protein ex-
pression. We also showed that the full-length and a nested
set of five COOH-terminally truncated occludins were all
localized at tight junctions as defined by colocalization
with endogenous occludin and ZO-1. By immunoprecipi-
tating detergent-solubilized membranes under nondena-
turing conditions, we report here for the first time that ex-
ogenous truncated chicken occludin interacted with
endogenous  Xenopus occludin in vivo to form an oligomer
during the tight junction assembly.
Figure 6. Immunocolocalization of Xenopus ZO-1 with the pro-
tein directed by mutant 266, the most truncated occludin in Xeno-
pus embryos. Frozen sections were made of embryos injected
with mutant 266 mRNA and stained with either anti–ZO-1 (a) or
with anti-FLAG M2 (b). The arrowheads indicate the colocaliza-
tion of both proteins at the junctional complexes. Bar, 10 mm.
Figure 7. The interaction of
Xenopus occludin with
chicken occludin in vivo as-
sayed by immunoprecipita-
tion. The embryos were mi-
croinjected with the most COOH-terminally truncated occludin
mRNA (266; a and b, left lanes) or water (C; a and b, right lanes)
and incubated at room temperature for 10 h. After homogeniza-
tion, the samples were centrifuged at 100,000 g for 30 min at 48C.
The membrane pellet was solubilized in modified RIPA buffer
(see Materials and Methods) and centrifuged at 100,000 g for 1 h
at 48C. The resulting supernatant was immunoprecipitated with
anti-occludin 11350 (a) or anti-FLAG M2 (b) overnight at 48C.
Immunoprecipitates were immunoblotted with anti-FLAG M2
(a) or anti-occludin 11350 (b). A specific band corresponding to
the chicken truncated occludin (compare with Fig. 2 b, lane 266)
was present in a (left lane) after immunoprecipitated with anti-
occludin 11350. The Xenopus full-length occludin was observed
at b (left lane) after immunoprecipitated with anti–FLAG M2.
The two thick bands in b were IgG heavy chain.
Figure 8. Coimmunoprecipi-
tation of the mutant with en-
dogenous occludin was not
the result of exchange of
monomers between deter-
gent-solubilized oligomeric assemblies. Confluent A6 cell mono-
layers were metabolically labeled with 150 mCi/ml [35S]methio-
nine/cysteine for 20 h at 278C, solubilized under nondenaturing
conditions, and then mixed with similarly detergent-solubilized
supernatant from Xenopus embryos injected with 266 construct
mRNA at the two-cell stage and incubated for 10 h at room tem-
perature. After immunoprecipitation with anti-occludin 11350
(left lane), anti-FLAG M2 (middle lane), or preimmune rabbit
serum (right lane), samples were separated on 12% SDS-PAGE
and autoradiographed. 35S-labeled occludin could not be immu-
noprecipitated with anti-FLAG M2 (middle lane), demonstrating
that mixing of the mutant with wild-type molecules after extrac-
tion did not result in detergent-mediated exchange of protein
monomers. The bar above the arrowhead indicates the molecu-
lar weight marker 66 kD.The Journal of Cell Biology, Volume 138, 1997 898
The mechanism by which the full-length occludin res-
cued the tight junction phenotype was not clear. The activ-
ity of mutant 266 was sensitive to a dilution of 1:50 but not
1:10, suggesting a competitive inhibition of the endoge-
nous molecules. However, the oligomeric state of occludin
is not known, nor is the number of copies of occludin re-
quired per oligomer to disrupt activity. Since chicken oc-
cludin may have different binding constants for amphibian
molecules, it is not possible to predict the stoichiometries
required for inhibition. The rescue data do demonstrate
that the effects of the truncated molecules were not due to
cytotoxicity or other nonspecific effects, since coexpres-
sion of full-length occludin protein can rescue the mutant
phenotype.
In our studies, the FLAG signal could be detected in the
tight junctions in frozen sections 4 h after RNA injection.
This is consistent with the results obtained by McCarthy et
al. (1996), who found chicken occludin staining in tight
junctions of MDCK cells 4 h after addition of IPTG to the
Lac-inducible system. Electron microscopy of Xenopus
blastomeres expressing truncated occludins showed no ev-
idence of structural perturbation of the tight junctions
(data not shown), which was consistent with previously
published studies in MDCK cells (Balda et al., 1996). In-
jected embryonic blastomeres were lineage marked by
coinjection of 15 nm colloidal gold together with the mu-
tant occludin 266 mRNA. We observed no cell death ei-
ther grossly (Paul et al., 1995), or by electron microscopy
(data not shown), indicating that the truncated proteins
were not cytotoxic, and that the induced paracellular leaks
could be tolerated by the developing embryos.
A previous study showed that chicken occludin with 120
amino acids deleted from the COOH terminus failed to lo-
calize at tight junctions in transfected MDBK cells (Furuse
et al., 1994). In contrast, Balda et al. (1996) reported that
in transfected MDCK cells, a chicken occludin lacking al-
most the entire COOH-terminal domain was efficiently
transported to tight junctions. Their data indicate that this
truncated occludin causes a discontinuous junctional dis-
tribution of transfected and endogenous occludin. Our re-
sults were partially consistent with Balda et al. (1996) in
that COOH-terminally truncated occludin could be deliv-
ered to the tight junctions. We have not observed the dis-
continuous distribution pattern of mutant and endogenous
occludin in Xenopus embryos. This difference could be
due to the differences in the constructs used for study or in
the expression systems used.
Protein oligomerization is a common step in the assem-
bly of integral membrane proteins in cells, which usually
occurs in the endoplasmic reticulum (Hurtley and Hele-
nius, 1989) but may sometimes occur in the trans-Golgi
(Musil and Goodenough, 1993). In the present study, our
experimental data provide evidence that occludin formed
an oligomeric complex in vivo during tight junction assem-
bly, a finding consistent with the resolution of tight junc-
tion freeze-fracture strands as closely apposed 6–10-nm
particles (Raviola et al., 1980). An intact COOH terminus
on all copies of occludin in the oligomer is not required for
this oligomerization process, since a truncated occludin
will cooligomerize with full-length. While the intracellular
location is not known, occludin oligomerization occurred
in oocytes before tight junction assembly. In addition to its
association with endogenous occludin, truncated occludin
colocalized with ZO-1 by double immunofluorescence la-
beling, although it lacked a binding site for ZO-1 (Furuse
et al., 1994). Taken together, these data indicate that the
oligomerization of occludin occurred before the assembly
of the tight junction, and that the presence of full-length
endogenous occludin in the oligomeric assemblies pro-
vided the required signals for both ZO-1 binding and
membrane targeting.
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